Varian names C. Clifton Ling as director of Advanced Clinical Research

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Varian Medical Systems announced that it will appoint C. Clifton Ling, PhD, to the position of director of advanced clinical research for Oncology Systems. Ling is a world-renowned medical physicist who has been serving as chairman and attending physicist at Memorial Sloan Kettering Cancer Center in New York. He will play a key role in guiding the development of Varian's clinical products for radiotherapy and radiosurgery.

"Varian has had the privilege of collaborating with Clif Ling for many years in his role as a clinical physicist and radiation science researcher," said Tim Guertin, president and CEO. "He has been instrumental in the development of advanced treatment protocols for intensity modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT). He is respected around the world and we expect that he will be a tremendous asset to Varian in this important new role as we develop additional clinical capabilities including dynamic adaptive radiotherapy as well as protocols for biologically guided treatments."

Ling will join Varian in mid-July, and will continue to do hypoxia imaging research on a part-time basis at Memorial Sloan Kettering Cancer Center. "I look forward to the opportunities and challenges in working with Varian to develop novel and improved tools and methods for multimodality cancer therapy," he said.

Ling has been the Enid Haupt Chair of Medical Physics at Memorial Sloan Kettering Cancer Center and has an extensive record of research and academic achievement. Among his numerous awards are the Coolidge Award of the American Association of Physicists in Medicine (AAPM) in 2004 and the Gold Medal of the American Society of Therapeutic Radiology and Oncology (ASTRO) in 2006, both the highest honor of the respective organization. In 1998, he was elected honorary member of the European Society of Therapeutic Radiology and Oncology (ESTRO). He has lectured as a named visiting professor at many institutions, including Harvard University/MGH, the University of California at San Francisco, Stanford University and Washington University. He has published more than 200 research papers on a broad range of topics in the radiation sciences and clinical radiotherapy, and he has contributed to dozens of books, chapters, editorials, and proceedings.